Starling Oncology (STLNW) EPS (Basic) (2020 - 2026)
Starling Oncology's (STLNW) quarterly EPS (Basic) came in at -$0.08 in Q2 2026, up 46.72% on a YoY basis from -$0.05 in Q2 2025, and down 288.86% quarter-over-quarter from -$0.02 in Q1 2026.
Powered by 
Analysis
Starling Oncology (STLNW) EPS (Basic) (2020 - 2026) Analysis & Trends
Starling Oncology (STLNW) has reported EPS (Basic) for 7 consecutive years, with -$0.08 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 46.72% year-over-year to -$0.08; the trailing twelve-month figure through Jun 2026 stood at -$0.3 (up 48.96% YoY), and the FY2025 full-year result was -$0.54, up 22.91% from the prior year.
- EPS (Basic) declined to -$0.08 in Q2 2026 per STLNW's latest filing, from -$0.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.26 in Q1 2022 and bottomed at -$0.41 in Q1 2023.
- Historically, EPS (Basic) has averaged -$0.14 across 5 years, with a median of -$0.15 in 2025.
- The sharpest annual moves came in 2023 and 2026: EPS (Basic) plunged 540.03% in 2023, then surged 90.13% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.15 in 2022, then slumped by 68.18% to -$0.25 in 2023, then surged by 43.27% to -$0.14 in 2024, then jumped by 51.78% to -$0.07 in 2025, then declined by 14.98% to -$0.08 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.08, -$0.02, and -$0.07 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.96 Bn | 11.27 Bn | 1.16 Bn | 5.30 |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | 0.26 |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 2.62 |
| 4 | Concentra Group Holdings Parent | 4.29 Bn | 4.13 Bn | 192.10 Mn | 0.54 |
| 5 | Privia Health | 2.58 Bn | 2.16 Bn | - | 0.08 |
| 6 | Pediatrix Medical | 2.14 Bn | 1.74 Bn | - | 0.50 |
| 7 | Progyny | 2.11 Bn | 1.88 Bn | 89.30 Mn | 0.36 |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | 0.23 |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | 0.99 |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -0.08 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08 |
| Mar 31, 2026 | -0.02 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.14 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.14 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.27 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.23 |
| Mar 31, 2023 | -0.41 |
| Dec 31, 2022 | -0.15 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | 0.26 |
| Dec 31, 2021 | -0.15 |
| Sep 30, 2021 | -0.01 |